CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 303 enrolled
Drug / intervention
Polypill (atorvastatin, amlodipine, losartan, and hydrochlorothiazide)drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02278471
NCT02278471Phase 2Completed
CompareCT.gov

The SCCS Polypill Pilot Trial

Vanderbilt University·interventional·Posted Oct 30, 2014·Updated May 14, 2021

In Brief

A Phase 2 clinical trial evaluating Polypill (atorvastatin, amlodipine, losartan, and hydrochlorothiazide) for Hypertension and Hyperlipidemia. Completed, enrolled 303 participants across 1 site.

Detailed Summary

In this study the investigators will examine the effect of the polypill on medication adherence, systolic blood pressure, and LDL cholesterol over a 12 month span.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension, Hyperlipidemia
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 30, 2014
Enrollment StartDec 1, 2015
Primary CompletionJun 27, 2018
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 11.7 years ago

Interventions

Polypill (atorvastatin, amlodipine, losartan, and hydrochlorothiazide)drug